FWA
GILD icon

Flagship Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Flagship Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39K Buy
309
+10
+3% +$1.32K 0.01% 296
2026
Q1 		$33.1K Hold
299
– – 0.01% 218
2025
Q4 		$36.7K Hold
299
– – 0.01% 244
2025
Q3 		$33.2K Hold
299
– – 0.01% 254
2025
Q2 		$33.1K Buy
+299
New +$31.8K 0.01% 233

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Flagship Wealth Advisors's GILD Position: Q2 2026 in Review

Flagship Wealth Advisors increased its Gilead Sciences (GILD) stake by 3.3% in Q2 2026, buying an estimated $1.32K and bringing the position to 309 shares worth $39K. The position accounts for 0.01% of the portfolio, ranked #296.

Flagship Wealth Advisors first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Flagship Wealth Advisors held 309 shares of Gilead Sciences worth $39K as of Q2 2026.
  • Flagship Wealth Advisors bought 10 Gilead Sciences shares in Q2 2026, an estimated $1.32K.
  • Gilead Sciences made up 0.01% of Flagship Wealth Advisors's portfolio in Q2 2026, its #296 holding.
  • Flagship Wealth Advisors first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Flagship Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.